Free tool
Stocks near their 52-week high
We cover 60 companies trading within 5% of their own 52-week high. The median market value in the group is $8.19B. Across the group, the median move over the past trading day is +1.06%. 98% of the 58 with a 200-day average trade above it. Price change over the past year runs from +4.3% to +95.3% across the middle 80 percent of the group, with a median of +37.1%. Across the group, 4 companies currently carry a tier A volume signal.
Other lists in this group
Table
60 of 3,992 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| LLY.DE | Eli Lilly and Company | 1,080.40 EUR | +0.43% | +19.60% | +73.55% |
| JNJ.DE | Johnson & Johnson | 234.20 EUR | −0.62% | +34.82% | +58.93% |
| 4AB.DE | AbbVie Inc. | 228.40 EUR | −2.56% | +19.14% | +32.34% |
| 6MK.DE | Merck & Co., Inc. | 132.16 EUR | +14.19% | +47.92% | +91.49% |
| RHO.DE | Roche Holding AG | 405.40 EUR | +2.01% | +14.00% | +41.42% |
| AMG.DE | Amgen Inc. | 382.20 EUR | +10.65% | +39.41% | +60.12% |
| TN8.DE | Thermo Fisher Scientific Inc. | 537.00 EUR | +5.63% | +6.86% | +29.67% |
| GIS.DE | Gilead Sciences, Inc. | 126.78 EUR | +7.51% | +23.41% | +33.64% |
| PFE.DE | Pfizer Inc. | 24.44 EUR | +10.09% | +18.44% | +22.96% |
| VX1.DE | Vertex Pharmaceuticals Incorporated | 475.00 EUR | +10.21% | +23.55% | +41.64% |
| 0QF.DE | Moderna, Inc. | 136.12 EUR | +181.04% | +417.17% | +550.51% |
| QTS.DE | IQVIA Holdings Inc. | 222.10 EUR | +19.34% | +15.23% | −4.04% |
| ILU.DE | Illumina, Inc. | 193.08 EUR | +13.91% | +69.73% | +129.80% |
| DC4.DE | DexCom, Inc. | 77.60 EUR | +16.52% | +37.44% | +21.06% |
| IDP.DE | Biogen Inc. | 190.12 EUR | +0.21% | +26.49% | +65.32% |
| GMAB.CO | Genmab A/S | 2,196.00 DKK | +17.62% | +9.42% | +36.19% |
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | 469.60 SEK | −0.76% | +42.13% | +61.26% |
| IPN.PA | Ipsen S.A. | 166.00 EUR | +1.41% | +42.98% | +40.80% |
| ESF0.DE | Eurofins Scientific SE | 72.70 EUR | +7.58% | +17.51% | +12.65% |
| ERF.PA | Eurofins Scientific SE | 74.08 EUR | +7.93% | +20.90% | +15.60% |
| ORNBV.HE | Orion Oyj | 80.80 EUR | −1.76% | +29.38% | +21.01% |
| ORNAV.HE | Orion Oyj | 80.50 EUR | −1.83% | +29.71% | +21.27% |
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | 52.70 EUR | +2.53% | +10.68% | +1.80% |
| DEMANT.CO | Demant A/S | 284.60 DKK | +0.21% | +33.36% | +17.12% |
| GETI-B.ST | Getinge AB (publ) | 243.30 SEK | +2.18% | +14.56% | +20.89% |
| HLUN-A.CO | H. Lundbeck A/S | 42.25 DKK | +16.39% | +18.14% | +29.71% |
| 1SXP.DE | SCHOTT Pharma AG & Co. KGaA | 23.00 EUR | +3.84% | +58.22% | +1.26% |
| BBZA.DE | BB Biotech AG | 33.40 EUR | 0.00% | +7.22% | +7.22% |
| BV3.DE | Bavarian Nordic A/S | 29.26 EUR | +23.46% | +13.19% | +15.65% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | 111.20 EUR | +15.35% | +66.79% | +70.53% |
| VIMIAN.ST | Vimian Group AB (publ) | 35.35 SEK | +1.58% | +15.22% | +12.01% |
| ATT.ST | Attendo AB (publ) | 117.90 SEK | +7.57% | +49.22% | +80.74% |
| AMBEA.ST | Ambea AB (publ) | 173.60 SEK | +21.74% | +27.37% | +38.66% |
| AMS.L | Advanced Medical Solutions Group plc | 281.50 GBP | +0.36% | +29.14% | +38.01% |
| UU8.F | Neurogene Inc. | 33.20 EUR | +21.17% | +29.18% | +165.60% |
| HNSA.ST | Hansa Biopharma AB (publ) | 43.30 SEK | +19.22% | +32.42% | +35.65% |
| EGTX.ST | Egetis Therapeutics AB (publ) | 7.87 SEK | +25.72% | +52.22% | +51.35% |
| HUM.ST | Humana AB (publ) | 71.70 SEK | +14.72% | +46.12% | +81.84% |
| ANCR.L | Animalcare Group PLC | 335.00 GBP | 0.00% | +40.76% | +28.86% |
| MED.DE | MEDICLIN Aktiengesellschaft | 5.45 EUR | +31.64% | +51.39% | +75.81% |
| TRMED.OL | Thor Medical ASA | 6.76 NOK | +51.91% | +34.93% | +135.13% |
| XUP.DE | Genfit S.A. | 14.08 EUR | −1.81% | +164.41% | +166.82% |
| AOTI.L | AOTI, Inc. | 142.50 GBP | +35.71% | +418.18% | +159.09% |
| LIK.DE | LIMES Schlosskliniken AG | 570.00 EUR | −0.87% | +58.33% | +70.66% |
| ALECR.PA | Eurofins-Cerep SA | 17,700.00 EUR | +8.59% | −0.56% | −3.80% |
| INIFY.OL | INIFY Laboratories AB | 7.95 NOK | −3.05% | +65.63% | +44.55% |
| SAR.L | Sareum Holdings plc | 37.00 GBP | +76.19% | +117.65% | +76.19% |
| OHGR.L | One Health Group Plc | 292.50 GBP | +10.38% | +16.53% | +17.03% |
| BION.SW | BB Biotech AG | 56.70 CHF | +8.21% | +37.62% | +84.12% |
| BSLN.SW | Basilea Pharmaceutica AG | 65.30 CHF | +24.62% | +19.82% | +40.88% |
| GXI.SW | Gerresheimer AG | 25.28 CHF | −1.71% | +2.10% | +2.10% |
| LONN.SW | Lonza Group AG | 587.80 CHF | +2.26% | +10.90% | +4.28% |
| NOVN.SW | Novartis AG | 128.34 CHF | −1.08% | +21.88% | +30.24% |
| RO.SW | Roche Holding AG | 379.00 CHF | +1.99% | +17.47% | +41.81% |
| ROP.SW | Roche Holding AG | 373.80 CHF | +3.35% | +18.35% | +47.60% |
| SDZ.SW | Sandoz Group AG | 73.54 CHF | +9.01% | +30.08% | +47.80% |
| SKAN.SW | SKAN Group AG | 65.70 CHF | +9.87% | +26.45% | +6.80% |
| SOON.SW | Sonova Holding AG | 245.00 CHF | +10.16% | +17.62% | +6.01% |
| TECN.SW | Tecan Group AG | 193.30 CHF | +4.20% | +48.97% | +19.14% |
| YPSN.SW | Ypsomed Holding AG | 407.20 CHF | +4.36% | +24.15% | +4.01% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.